The PMS fund manager projects a nominal GDP growth rate of 10-11% over the next decade, providing a strong foundation for corporate earnings to grow at 13-14% annually
Nirmal Bang recommends buying Epigral and Suryoday Small Finance Bank for May. Epigral shows growth potential with revenue and PAT increase despite challenges. Suryoday is expected to focus on growth after the restructuring exercise, aiming for advances growth and narrowing the valuation gap.
Says there has been a remarkable decentralisation of profits, with smaller companies witnessing a surge in profitability thanks to factors like the implementation of GST, expansion of highway networks
Foreign institutional investors (FII) have been the largest non-promoter investor category in Indian stock markets. But, that is expected to change soon. Fuelled by a surge in investments flowing into mutual funds, domestic institutional investors (DII) could overtake their foreign counterparts in coming quarters